FindTrial
Sign In

Study for Comprehensive Prevention and Treatment of Lung Cancer in Traditional Chinese

Study for Comprehensive Prevention and Treatment of Lung Cancer in Traditional Chinese

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021010
Enrollment
Unknown
Registered
2019-01-25
Start date
2018-01-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Treatment Group:The guidelines recommend the standard treatment based on the addition of Chinese Medicine treatment options
Control group:Only recommended oncology treatments for the relevant guidelines, including surgery, chemotherapy, radiotherapy, etc.

Sponsors

Gansu Cancer Institute & Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria in the code for the diagnosis and treatment of common malignant tumors prepared by the medical and political department; 2. Karnofsky score greater than or equal to 60 points; 3. Aged 18-80 years; 4. The examination indexes conform to the adaptation certificate of treatment; 5. To be willing to receive treatment and cooperate with the Doctor.

Exclusion criteria

Exclusion criteria: 1. Non-compliance with inclusion criteria; 2. Women during pregnancy or lactation; 3. Combine severe cardiovascular and cerebrovascular diseases or disorders such as mental disorders.

Design outcomes

Primary

MeasureTime frame
Treatment completion Rate;Efficacy of solid tumors;Evaluation of tumor marker change: Observation of CEA, SCC, yFRA211 index changes.;—

Countries

China

Contacts

Public ContactXiaojun Xia

Gansu Cancer Institute & Hospital

xiaxiaojun2006@126.com+86 13609312066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026